Neomyx (Tamsulosin Hydrochloride, Dutasteride)

Neomyx is used to manage conditions related to benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms.

• Benign prostatic hyperplasia: improves urinary flow and reduces symptom severity.
• Enlarged prostate: decreases prostate volume over time.
• Lower urinary tract symptoms due to BPH: lessens frequency, urgency and nocturia.

• Neomyx combines two agents that act on the prostate. Tamsulosin selectively blocks alpha-1 adrenergic receptors on prostatic smooth muscle, causing relaxation and lowering urinary outflow resistance. Dutasteride inhibits both type I and type II 5-alpha-reductase enzymes, reducing conversion of testosterone to dihydrotestosterone, which leads to a gradual reduction in prostate gland size. The complementary actions improve urinary symptoms in men with BPH.

Neomyx may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects

• Dizziness or light‑headedness, especially on standing.
• Headache.
• Abnormal ejaculation or reduced libido.
• Nasal congestion or runny nose.
• Orthostatic hypotension.
• Gastrointestinal discomfort such as nausea.

Serious or Rare Side Effects

• Severe hypotension or syncope.
• Intraoperative floppy iris syndrome during cataract surgery.
• Allergic reactions including rash, swelling or anaphylaxis.
• Hepatic dysfunction or elevated liver enzymes.

Before prescribing Neomyx, clinicians should consider several precautionary measures to ensure patient safety.

• Monitor blood pressure: watch for orthostatic changes, especially after initiating therapy.
• Assess liver function: dutasteride is metabolized hepatically and may require periodic testing.
• Avoid use in patients with known hypersensitivity to either component.
• Caution in men scheduled for cataract surgery: increased risk of intraoperative floppy iris syndrome.
• Contraindicated in pregnancy and breastfeeding: fetal exposure to dutasteride can cause abnormalities.
• Store at room temperature: keep in the original container, protect from moisture and light.

Neomyx can interact with other medicines, and some combinations require avoidance or close monitoring.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise dutasteride levels.
• Other alpha‑blockers (e.g., prazosin, doxazosin): additive hypotensive effect.
• Anticoagulants such as warfarin: potential increase in bleeding risk.

Moderate Interactions (Monitor Closely)

• Antihypertensives (ACE inhibitors, ARBs): monitor blood pressure for additive lowering.
• Diuretics: watch for electrolyte disturbances and enhanced hypotension.
• Rifampin or other CYP3A4 inducers: may reduce dutasteride efficacy.